# The Human Medicines Regulations 2012, Paragraph 17


Details of any decision in a country other than the United Kingdom to refuse to grant an authorisation or registration allowing the medicinal product to be placed on the market, with the reasons for any such decision.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/12/paragraph/17 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-12/paragraph-17
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.